← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Universidad Peruana Cayetano Heredia
Lima
$61,462,630
Total funding
71
Grants
Funding over time
peak $6M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$55,841,981 · 68
CDC$3,917,603 · 1
DOD$1,703,046 · 2
By mechanism
D43$14,831,240 · 6
U01$13,685,281 · 6
R01$8,713,137 · 13
UH3$4,214,806 · 1
P50$3,213,341 · 5
U19$2,895,442 · 6
Investigators at Universidad Peruana Cayetano Heredia
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Largest grants
COOPERASALUD II: TECHNICAL ASSISTANCE TO STRENGTHEN POST-PANDEMIC HIV PREVENTION AND CONTROL CAPACITIES IN THE PERUVIAN ARMED FORCES$1,553,046
· FY2025 · Defense Health Agency
Global Health Activities in Developing Countries to Combat Non-Communicable Chron$1,427,451
N01 · FY2009 · HL
Addressing HyperteNsion and Diabetes through Community-Engaged Systems in Puno Peru (ANDES study)$1,422,658
UH3 · FY2023 · HL
Addressing HyperteNsion and Diabetes through Community-Engaged Systems in Puno Peru (ANDES study)$1,405,550
UH3 · FY2025 · HL
Addressing HyperteNsion and Diabetes through Community-Engaged Systems in Puno Peru (ANDES study)$1,386,598
UH3 · FY2024 · HL
RFA-GH-20-005, Project of Febrile Illness Surveillance in the Andean and Amazon Countries (PISAAC)$997,603
U01 · FY2023 · GH
A multicenter, randomized controlled trial of single and multiple dose regimes of oxfendazole for mild (one or two lesions) parenchymal brain cysticercosis$944,056
U01 · FY2024 · AI
A multicenter, randomized controlled trial of single and multiple dose regimes of oxfendazole for mild (one or two lesions) parenchymal brain cysticercosis$941,896
U01 · FY2025 · AI
Project of Febrile Illness Surveillance in the Andean and Amazon Countries (PISAAC)$750,000
U01 · FY2022 · GH
RFA-GH-20-005, Project of Febrile Illness Surveillance in the Andean and Amazon Countries (PISAAC)$750,000
U01 · FY2024 · GH
Project of Febrile Illness Surveillance in the Andean and Amazon Countries (PISAAC)$710,000
U01 · FY2020 · GH
Project of Febrile Illness Surveillance in the Andean and Amazon Countries (PISAAC)$710,000
U01 · FY2020 · GH
New Tools to Understand and Control Endemic Parasites$702,790
P01 · FY2005 · AI
New Tools to Understand and Control Endemic Parasites$701,667
P01 · FY2006 · AI
New Tools to Understand and Control Endemic Parasites$681,995
P01 · FY2004 · AI
New Tools to Understand and Control Endemic Parasites$667,596
P01 · FY2003 · AI
Innovative Approaches to Diagnosis and Control of Chagas Disease (Peru TMRC)$649,983
P50 · FY2007 · AI
Innovative Approaches to Diagnosis and Control of Chagas Disease (Peru TMRC)$647,189
P50 · FY2011 · AI
Innovative Approaches to Diagnosis and Control of Chagas Disease (Peru TMRC)$645,385
P50 · FY2010 · AI
Addressing HyperteNsion and Diabetes through Community-Engaged Systems in Puno, Peru (ANDES study)$641,044
UG3 · FY2020 · HL